ReviewGut and liver2023

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan.

Shigenori Ei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.